Next Article in Journal
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey
Next Article in Special Issue
In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface
Previous Article in Journal
“The 24th Conference” of the Groupement des Pharmacochimistes de l’Arc Atlantique (GP2A)
Previous Article in Special Issue
Exploring the CK2 Paradox: Restless, Dangerous, Dispensable
 
 
Review

Article Versions Notes

Pharmaceuticals 2017, 10(1), 18; https://doi.org/10.3390/ph10010018
Action Date Notes Link
article pdf uploaded. 28 January 2017 09:15 CET Version of Record https://www.mdpi.com/1424-8247/10/1/18/pdf-vor
article pdf uploaded. 3 February 2017 12:22 CET Updated version of record https://www.mdpi.com/1424-8247/10/1/18/pdf
article xml uploaded. 3 February 2017 12:22 CET Original file https://www.mdpi.com/1424-8247/10/1/18/xml
article html file updated 3 February 2017 12:23 CET Original file -
article html file updated 31 March 2017 05:33 CEST Update -
article html file updated 27 October 2017 10:30 CEST Update -
article html file updated 9 November 2017 12:31 CET Update -
article html file updated 4 May 2019 13:13 CEST Update -
article html file updated 23 September 2019 02:34 CEST Update -
article html file updated 7 February 2020 22:25 CET Update -
article html file updated 16 July 2022 04:41 CEST Update https://www.mdpi.com/1424-8247/10/1/18/html
Back to TopTop